arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ASP Isotopes Inc.

ASPI
$1.71 ▼ -0.21 (-10.70%) at close
Materials ·Miscellaneous Chemical Products ·USMiscellaneous Chemical Products
20 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

ASP Isotopes Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $209.8M
Dividend Yield —
Revenue Growth 327.5% ↗
Op. Margin None
ROIC -10.5% ↘
FCF / Share $-0.22 ↘
Trailing P/E —
Price / Book 0.8x
FCF Yield —
Debt / Equity 0.23
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.12M
↑ +327.5% —
Net Income Profit after all expenses
$-33.99M
↓ -301.7% —
Operating Margin Operating profit as % of sales
-150.2%
↑ +50.9% 0th
FCF / Share Free cash flow per share
$-0.22
↓ -13.2% —
Long-Term Debt Long-term obligations
$59.77M
↑ +2.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns ↓
11
Financial Health ↑
43
Cash Quality ↓
32

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 20 quarters